| Spirig HealthCare AG - Rivaroxaban Spirig HC 20 mg, Filmtabletten | | 68552 | | 03 | | Rivaroxaban Spirig HC 20 mg | | Filmtabletten | | B01AF01 | | Rivaroxaban | | 16.03.2023 | | |
| | Composition | | rivaroxabanum 20 mg, cellulosum microcristallinum, lactosum monohydricum 56.664 mg, povidonum K 30, amylum pregelificatum, crospovidonum, natrii laurilsulfas, magnesii stearas, Überzug: hypromellosum, E 171, macrogolum 4000, E 172 (rubrum), pro compresso obducto corresp. natrium 0.04 mg. | | Packungsbestandteile | | Comprimés filmés | | | | | Principe actif | Concentr. |
|---|
| Rivaroxabanum | 20 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Rivaroxabanum | 20 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| (Rubrum) | | | | Amylum Pregelificatum | | | | Cellulosum Microcristallinum | | | | Crospovidonum | | | | E 171 | | color. | | E 172 | | color. | | Hypromellosum | | Überzug | | Lactose Monohydrate | 56.664 mg | | | Macrogol | 4000 | | | Magnesii Stearas | | | | Natrii Laurilsulfas | | | | Povidonum K | 30 | | | Pro Compresso Obducto | | |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 007 | 14 | 9.71 | 27.00 | B | LS | Non | | 008 | 28 | 18.85 | 36.90 | B | LS | Non | | 009 | 98 | 69.13 | 91.60 | B | LS | Non |
|
|
